Hosted on MSN6d
Fortress doses first subject in Phase II CMV vaccine trial
Fortress Biotech and its subsidiary Helocyte have announced the dosing of the first subject in a multi-centre Phase II trial ...
Medscape4d
Management of Viral Infections in Solid Organ Transplant Recipients
Collectively, the eight members of the herpesvirus family are the most common viral pathogens causing disease after SOT. Herpesviruses are large enveloped DNA viruses that commonly reactivate ...
Medscape3d
Post-Infectious Gastroparesis: Clinical and Electerogastrographic Aspects
Patients' age ranged from 3 months to 47 years. A specific virus was identified in two patients (one cytomegalovirus [CMV] and one Epstein-Barr virus [EBV]). EGG was pathological in six out of ...